PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. [electronic resource]
- Medicine Dec 2018
- e13710 p. digital
Publication Type: Journal Article; Meta-Analysis
1536-5964
10.1097/MD.0000000000013710 doi
Diabetes Mellitus, Type 2--drug therapy Humans Hypoglycemic Agents--adverse effects Peptides--adverse effects Randomized Controlled Trials as Topic